Pull to refresh
Logo
What Changed
Following Why Sign Up
National Institutes of Health funds UW-Madison neutron capture therapy facility

National Institutes of Health funds UW-Madison neutron capture therapy facility

New Capabilities Madison, WI local

An $8 million NIH award funds UW-Madison's planned neutron capture therapy facility, the US's first accelerator-based clinical neutron-beam resource.

September 28th, 2026: Taiwan records its first breast cancer treatment with BNCT

Overview

Updated Oct 10

The National Institutes of Health has obligated $8 million to the University of Wisconsin System for a neutron capture therapy research facility in Madison. The award, recorded September 17 with work starting September 18, would give the US its first accelerator-based clinical neutron-beam resource. UW-Madison had already lined up the technology: in September 2025 it agreed with TAE Life Sciences, a California biotech, to install that firm's Alphabeam neutron source.

Neutron capture therapy kills tumor cells by activating a capture agent inside them with a neutron beam, delivering high doses to the cancer while limiting damage to healthy tissue. The project summary cites promising international results; in late September a Taiwan team reported shrinking tumors in five breast cancer patients. TAE's CEO told the Badger Herald that UW's first clinical trial could begin around early 2028.

Why it matters

The award could give the US its first accelerator-based clinical neutron capture therapy facility, a resource the project summary says the country currently lacks.

Last Monday's email for Madison, WI

Sent Nov 9. It carried:

Get next Monday's: one short email a week. Free. Unsubscribe in one click.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

$8M
NIH obligation to UW-Madison
Amount obligated in the federal award record; not a measure of spending to date.
1
U.S. accelerator-based clinical neutron-beam gap
The project summary states the U.S. lacks this resource, which the facility aims to create.
2026-09-18
Award work start date
Per the federal award record, activities under the grant begin September 18, 2026.
early 2028
Target for UW's first BNCT clinical trial
TAE Life Sciences CEO Robert Hill's estimate, per the Badger Herald, after the facility is built in the UW hospital complex and the Alphabeam machine is installed.

Voices

Curated perspectives — historical figures and your fellow readers.

Sign up to generate historical perspectives on this story.

Log in Sign Up

Organizations Involved

UW
University of Wisconsin System
Public university system
Grant recipient

The public university system that includes UW-Madison, the flagship research campus named in the award.
National Institutes of Health
National Institutes of Health
Federal research agency
Funder

The U.S. federal agency that funds and conducts medical research; source of the $8 million award.
TAE Life Sciences
TAE Life Sciences
Private biotechnology company
Technology partner

California biotechnology company developing the Alphabeam accelerator-based boron neutron capture therapy system that UW-Madison plans to install.

Timeline

September 2025 September 2026

4 events Latest: September 28th, 2026 · 1 month ago
Tap a bar to jump to that date

  1. Taiwan records its first breast cancer treatment with BNCT

    Latest Clinical

    National Tsing Hua University and two partner hospitals completed compassionate-use BNCT for five patients with recurrent triple-negative breast cancer, reporting significant tumor reduction. It is the first time Taiwan applied the method to breast cancer, expanding it beyond head-and-neck and brain cancer.

  2. Award work period begins

    Funding

    The federal record lists September 18 as the start date for activities under the grant.

  3. NIH records $8M UW-Madison award for neutron capture therapy facility

    Funding

    Federal award record shows $8 million obligated to the University of Wisconsin System, with Madison as the place of performance.

  4. TAE Life Sciences and UW-Madison sign MOU for US's first accelerator-based BNCT center

    Partnership

    The two agreed to install TAE's Alphabeam compact accelerator-based BNCT system at UW-Madison, which would be the first such center in the US. TAE also plans to supply boron-based drugs and help plan the facility.

Scenarios

1

UW-Madison opens national neutron capture therapy facility

Possible Resolves by End of 2029

Discussed by: NIH project summary and early coverage of the award

The $8 million obligation funds a facility designed to become the U.S.'s first accelerator-based clinical neutron-beam resource. If completed, it would enable clinical trials and eventually patient treatment, positioning UW-Madison as a national hub for neutron capture therapy.

2

Groundbreaking set for Wisconsin NCT facility

Likely Resolves by Q2 2028

Discussed by: Local Madison media and UW-Madison planning offices

Following the federal award, UW-Madison would announce a groundbreaking or construction start for the facility. The September 18 start date in the award record begins the grant period, though construction itself could come later.

3

Wisconsin NCT facility faces funding or construction delays

Possible Resolves by End of 2028

Discussed by: Large research-facility project track records

Research-facility projects often exceed initial budgets or hit permitting and supply-chain hurdles. If the $8 million obligation proves insufficient, UW-Madison may need supplemental funding, or the project may be scaled back or delayed.

4

UW-Madison starts first US clinical trial of accelerator-based BNCT

Likely Resolves by Q2 2028

Discussed by: TAE Life Sciences CEO Robert Hill, in the Badger Herald

After the facility is built in the UW hospital complex and the Alphabeam machine is installed (about six months), UW would seek FDA approval for a clinical trial. Hill said the first trial could begin around early 2028.

Historical Context

3 moments from history that rhyme with this story — and how they unfolded.

1951-1961

Brookhaven National Laboratory BNCT trials (1951-1961)

First clinical trials of boron neutron capture therapy used a nuclear reactor at Brookhaven National Laboratory on Long Island. Physicians treated brain tumors, but the boron compound did not concentrate well in tumors, and the neutron beam lacked depth penetration.

Then

Results were disappointing, and clinical BNCT largely halted in the U.S. for decades.

Now

Established benchmarks for boron delivery and beam quality that later researchers had to meet.

Why this matters now

This early failure explains why the U.S. fell behind in clinical neutron capture therapy, setting up the gap the UW-Madison grant aims to close.

2020

Japan approves accelerator-based BNCT (2020)

Sumitomo Heavy Industries' NeuCure system, a compact accelerator-based neutron source, received Japanese regulatory approval for treating recurrent head and neck cancer. It was the world's first approved accelerator-based BNCT system.

Then

Japan became the first country to offer clinical accelerator-based BNCT outside a reactor setting.

Now

Proved the technology could move into hospitals, spurring global interest in the field.

Why this matters now

The project summary cites the international resurgence the UW-Madison grant responds to; Japan is a leading example of the capability the U.S. currently lacks.

1999-2012

Finland's Helsinki BNCT program (1999-2012)

Helsinki University Hospital operated a reactor-based BNCT facility using the Fir 1 reactor, treating head and neck cancers and brain tumors. The program generated long-term outcome data showing benefits for some patients.

Then

Provided a European clinical experience base for neutron capture therapy.

Now

Supported the case for newer accelerator-based systems by showing real-world clinical value.

Why this matters now

This is one of the international clinical programs behind the promising outcomes the project summary references.

Sources

(6)
USAspending.gov Wisconsin Department of Public Instruction Business Wire The Badger Herald MarketMinute (GlobeNewswire) UW School of Medicine and Public Health